Recombinant Staphylococcus aureus 6,7-dimethyl-8-ribityllumazine synthase (ribH)

What is 6,7-dimethyl-8-ribityllumazine synthase (ribH) and what is its role in S. aureus?

6,7-dimethyl-8-ribityllumazine synthase (ribH) is a critical enzyme in the riboflavin (vitamin B2) biosynthetic pathway. In Staphylococcus aureus, as in other bacteria, this enzyme catalyzes the penultimate step in riboflavin biosynthesis - specifically, it facilitates the condensation of 5-amino-6-(D-ribitylamino)uracil with 3,4-dihydroxy-2-butanone 4-phosphate to form 6,7-dimethyl-8-ribityllumazine. This reaction is essential for the production of riboflavin, which serves as a precursor for flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), critical cofactors for numerous metabolic processes .

In bacterial systems, ribH typically forms part of a multi-enzyme complex involved in riboflavin biosynthesis. Understanding this enzyme's structure and function is important not only for basic bacterial physiology but also because the riboflavin biosynthetic pathway is absent in humans, making it a potential antimicrobial target.

What expression systems are most effective for producing recombinant S. aureus ribH?

For successful expression of recombinant S. aureus ribH, Escherichia coli remains the most widely used and effective heterologous expression system. When selecting an expression system, consider these methodological approaches:

The pET expression system utilizing E. coli BL21(DE3) or similar strains is particularly effective for recombinant expression of S. aureus proteins. This system places the gene of interest under the control of a T7 promoter, allowing for high-level, inducible expression. For optimal results, incorporate a 6xHis tag either at the N-terminus or C-terminus to facilitate purification, while being mindful that tags can sometimes affect enzyme activity .

Temperature modulation is critical during expression. While standard protocols often suggest 37°C for bacterial growth, lowering the expression temperature to 16-25°C after induction can significantly improve the solubility of recombinant S. aureus proteins. The reduced temperature slows protein synthesis, allowing more time for proper folding and reducing inclusion body formation .

The expression protocol should be optimized according to the following parameters:

It's worth noting that recombinant toxins from S. aureus expressed in E. coli have been successfully produced with full biological activity, suggesting that this expression system is suitable for S. aureus proteins like ribH .

What purification strategies yield the highest purity recombinant S. aureus ribH?

Purifying recombinant S. aureus ribH to high homogeneity requires a strategic multi-step approach. The following methodological strategy consistently yields enzyme preparations with >95% purity suitable for structural and functional studies:

Immobilized Metal Affinity Chromatography (IMAC) serves as an excellent first purification step when the recombinant ribH contains a histidine tag. Nickel or cobalt resins are particularly effective, with elution using an imidazole gradient (20-250 mM). This initial step typically achieves 70-80% purity. For optimal results, include low concentrations of reducing agents (1-5 mM β-mercaptoethanol or DTT) in all buffers to prevent oxidation of cysteine residues, and maintain a pH between 7.5-8.0 to maximize binding specificity .

Following IMAC, ion exchange chromatography provides further purification. Given that 6,7-dimethyl-8-ribityllumazine synthase from Bacillus subtilis (which shares structural similarities with S. aureus ribH) has a theoretical pI of 5.19, anion exchange chromatography using Q-Sepharose at pH 8.0 is highly effective for removing contaminants .

Size exclusion chromatography serves as a final polishing step, separating the target enzyme from any remaining impurities based on molecular size. For ribH, which typically forms a homo-oligomeric complex, a Superdex 200 column equilibrated with a buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 1 mM DTT provides excellent resolution.

When employing this three-step purification process, researchers should expect yields of 10-15 mg of highly pure recombinant ribH per liter of bacterial culture. The purified enzyme should be stored in buffer containing 20% glycerol at -80°C to maintain activity for at least 6 months.

How can I assess the activity of purified recombinant S. aureus ribH?

Assessing the enzymatic activity of recombinant S. aureus 6,7-dimethyl-8-ribityllumazine synthase requires specialized assays that monitor either substrate consumption or product formation. The following methodological approaches provide reliable quantification of ribH activity:

The spectrophotometric assay monitors the formation of 6,7-dimethyl-8-ribityllumazine, which absorbs at 408-410 nm. The standard reaction mixture contains 100 mM potassium phosphate buffer (pH 7.0), 5 mM MgCl₂, 5 μM purified ribH enzyme, 100 μM 5-amino-6-(D-ribitylamino)uracil, and varying concentrations of 3,4-dihydroxy-2-butanone 4-phosphate (10-200 μM). The increase in absorbance at 408-410 nm is measured over time at 37°C, with activity calculated using the molar extinction coefficient of 6,7-dimethyl-8-ribityllumazine (approximately 10,200 M⁻¹ cm⁻¹).

For more sensitive detection, especially with low enzyme concentrations, the HPLC-based assay provides superior resolution. After incubating the enzyme with substrates under the conditions described above, the reaction is terminated by adding trichloroacetic acid to a final concentration of 5%. Following centrifugation, the supernatant is analyzed by reverse-phase HPLC using a C18 column with gradient elution (5-30% acetonitrile in 0.1% trifluoroacetic acid). The 6,7-dimethyl-8-ribityllumazine product is detected by absorbance at 408 nm, with quantification based on a standard curve.

Remember that ribH shows interesting substrate specificity characteristics - it preferentially uses the natural S enantiomer of 3,4-dihydroxy-2-butanone 4-phosphate, but can also utilize the non-natural R enantiomer with reduced efficiency . This property can be explored by comparing reaction rates with different substrate enantiomers.

Kinetic parameters for recombinant S. aureus ribH can be determined by varying substrate concentrations and fitting the data to the Michaelis-Menten equation. Typical Km values for 3,4-dihydroxy-2-butanone 4-phosphate are in the low micromolar range (10-50 μM), while Vmax values vary depending on the specific preparation and assay conditions.

How should I design a randomized controlled trial to evaluate ribH inhibitors?

Designing a robust randomized controlled trial (RCT) to evaluate potential inhibitors of S. aureus ribH requires careful consideration of experimental variables, controls, and statistical power. The following methodological framework will ensure scientifically rigorous evaluation:

First, establish a clear hypothesis with defined primary and secondary endpoints. For example, your primary endpoint might be "50% inhibition of ribH enzymatic activity" while secondary endpoints could include "bacterial growth inhibition" or "reduction in riboflavin production." This clarity in objectives will guide all subsequent experimental design decisions .

Implement a true randomized controlled design by randomly assigning test compounds to experimental groups. Randomization should be performed using validated algorithms rather than arbitrary selection. The control groups must include: (1) a negative control (vehicle only), (2) a positive control (known inhibitor if available), and (3) appropriate controls for compound solubility and stability .

The experimental design should be double-blind whenever possible, meaning that both the researcher conducting the assays and the data analyst are unaware of which samples contain test compounds versus controls. This minimizes unconscious bias in data collection and interpretation .

For inhibitor screening, use the following experimental design matrix:

Sample size determination is critical. Power analysis should be performed prior to experimentation, typically aiming for 80-90% power to detect a statistically significant difference at α = 0.05. For in vitro enzyme inhibition studies, this typically requires 6-9 replicates per condition .

For data analysis, employ appropriate statistical methods based on data distribution. For dose-response relationships, use nonlinear regression to determine IC50 values. For comparing multiple conditions, use ANOVA with appropriate post-hoc tests after verifying data normality. Calculate confidence intervals to indicate the precision of your estimates .

Remember that successful RCTs minimize systematic errors through proper randomization, reduce detection bias through blinding, and control for confounding variables through appropriate experimental controls .

How can contradictions in ribH experimental data be systematically analyzed and resolved?

When facing contradictory results in ribH experimental data, a structured approach to data quality assessment and contradiction resolution is essential. Contradictions in biochemical data typically stem from variations in experimental conditions, reagent quality, or methodological differences. The following systematic framework helps identify and resolve such contradictions:

First, implement a structured classification of contradictions using the (α, β, θ) notation system, where α represents the number of interdependent items, β is the number of contradictory dependencies defined by domain experts, and θ is the minimal number of required Boolean rules to assess these contradictions . For enzyme kinetics data, typical contradictions fall into the (3,2,1) or (4,3,2) classes, representing complex relationships between substrate concentration, enzyme concentration, inhibitor presence, and measured activity.

Create a contradiction matrix to visualize relationships between experimental variables. For example:

When analyzing contradictory experimental results for ribH activity studies, implement the following resolution strategies:

• Reagent authentication: Verify the integrity of key reagents, particularly substrate purity and enantiomeric composition. The ribH enzyme is known to have differential activity with R versus S enantiomers of 3,4-dihydroxy-2-butanone 4-phosphate .

• Methodological comparison: Implement multiple orthogonal assays simultaneously (e.g., spectrophotometric and HPLC-based methods) to identify method-dependent variations.

• Boolean rule minimization: For complex multivariable contradictions, apply Boolean minimization techniques to reduce the dimensionality of the problem and identify core contradictory relationships .

• Meta-analysis approach: When contradictions appear across multiple studies, implement formal meta-analytical techniques with random-effects models to account for between-study heterogeneity.

Remember that even well-designed studies can produce apparently contradictory results due to subtle differences in experimental conditions. The goal is not necessarily to eliminate all contradictions but to understand their source and use this understanding to refine experimental models and theoretical frameworks .

What structural analysis techniques are most informative for S. aureus ribH characterization?

Comprehensive structural characterization of recombinant S. aureus 6,7-dimethyl-8-ribityllumazine synthase requires a multi-technique approach that reveals different aspects of protein structure and dynamics. The following methodological strategy provides complementary structural insights:

X-ray crystallography remains the gold standard for high-resolution structural determination of ribH. For optimal crystal formation, purified ribH (10-15 mg/ml) should be screened against sparse matrix conditions using sitting or hanging drop vapor diffusion methods. Successful crystallization often occurs in conditions containing 15-25% PEG 3350/4000, 0.1-0.2 M salt (often ammonium sulfate), and buffers at pH 6.5-8.0. Co-crystallization with substrates or substrate analogs provides valuable insights into the active site architecture and catalytic mechanism. Data collection at synchrotron radiation sources typically yields structures with resolution better than 2.0 Å .

Cryo-electron microscopy (cryo-EM) has emerged as a powerful complementary technique, particularly for visualizing ribH in complex with larger binding partners or in different conformational states. Recent advances in cryo-EM have enabled near-atomic resolution structures of bacterial enzyme complexes . For ribH analysis, prepare samples at 2-5 mg/ml on glow-discharged grids, followed by plunge-freezing in liquid ethane. Data collection on modern electron microscopes equipped with direct electron detectors can resolve structural features to 2.5-3.5 Å resolution.

The following table compares the key structural analysis techniques for ribH characterization:

Molecular dynamics simulations complement experimental structures by revealing dynamic aspects of ribH function. Simulations of 100-500 ns using modern force fields can identify conformational changes associated with substrate binding and catalysis, particularly focusing on active site residues and their interactions with substrates .

For determining oligomeric states and conformational changes under different conditions, analytical ultracentrifugation and multi-angle light scattering provide valuable insights. These techniques allow precise determination of the molecular weight and stoichiometry of ribH complexes in solution under near-physiological conditions.

How does the regulation of ribH expression differ under standard versus stress conditions in S. aureus?

The transcriptional regulation of 6,7-dimethyl-8-ribityllumazine synthase (ribH) in Staphylococcus aureus exhibits complex patterns that vary significantly between standard growth conditions and various stress environments. Understanding these regulatory mechanisms requires examining both the promoter architecture and the transcription factors involved.

Under standard growth conditions, the ribH gene in S. aureus is primarily regulated by the housekeeping sigma factor σA (SigA), which controls constitutive expression of genes essential for basic cellular functions . The promoters recognized by σA typically contain canonical -35 (TTGACA) and -10 (TATAAT) elements separated by a 17±1 bp spacer. Transcriptional analysis reveals that ribH expression follows growth-phase dependent patterns, with highest expression during exponential growth phase when riboflavin demand is highest for various metabolic pathways .

In contrast, under stress conditions, ribH regulation shifts dramatically. Various stressors induce the alternative sigma factor σB (SigB) in S. aureus, which recognizes a distinct set of promoters characterized by different -35 and -10 elements with shorter spacer regions (typically 14-16 bp) . This regulatory switch allows the bacterium to adapt riboflavin biosynthesis to changing environmental conditions.

The following table summarizes the differential regulation of ribH under various conditions:

To experimentally determine ribH regulation patterns under different conditions, implement the following methodological approaches:

• Quantitative RT-PCR: Monitor ribH transcript levels relative to reference genes under various growth and stress conditions. This approach provides sensitive quantification of expression changes.

• Promoter-reporter fusions: Construct fusions of the ribH promoter region with reporter genes (e.g., GFP, luciferase) to visualize transcriptional activity in real time under different conditions.

• Chromatin immunoprecipitation (ChIP): Use antibodies against different sigma factors to determine which transcription factors bind to the ribH promoter under various conditions .

• RNA-seq: Perform global transcriptomic analysis to identify co-regulated genes and regulatory networks associated with ribH expression under different stress conditions.

Understanding the complex regulation of ribH expression provides insights into how S. aureus modulates riboflavin biosynthesis in response to environmental challenges, which may have implications for bacterial survival and pathogenesis.

What controls are essential when working with recombinant S. aureus ribH?

Rigorous experimental design for recombinant S. aureus 6,7-dimethyl-8-ribityllumazine synthase research requires carefully selected controls to ensure valid and reproducible results. The following methodological approach to controls addresses the most critical variables in ribH experiments:

When evaluating enzyme activity, implement a comprehensive set of negative and positive controls. The essential negative controls include: (1) no-enzyme control to assess non-enzymatic reaction rates or background signal; (2) heat-inactivated enzyme control (enzyme sample pre-treated at 95°C for 10 minutes) to confirm that observed activity is protein-dependent; and (3) no-substrate controls for each substrate to identify potential contamination issues .

For positive controls, use: (1) commercially available or well-characterized ribH from related species (e.g., Bacillus subtilis ribH) to benchmark your assay system; and (2) known modulators of enzyme activity to validate the sensitivity of your assay .

When examining substrate specificity, implement the following control matrix:

For protein expression and purification experiments, the following controls are essential: (1) empty vector control to distinguish host-specific background proteins; (2) untagged protein control if using affinity tags; (3) wild-type protein as reference when studying mutant variants; and (4) protease inhibitor controls to assess protein stability during purification .

When designing inhibitor studies, include solvent controls (e.g., DMSO at the same concentration as in test samples) to account for potential solvent effects on enzyme activity. Additionally, test compounds should be evaluated for potential interference with the detection method by running parallel assays with product standards in the presence of test compounds .

How can I optimize the experimental design for ribH catalytic mechanism studies?

Elucidating the catalytic mechanism of recombinant S. aureus 6,7-dimethyl-8-ribityllumazine synthase requires a multi-faceted experimental approach that combines kinetic, structural, and computational methods. The following integrated experimental design optimizes investigation of the ribH catalytic mechanism:

Begin with steady-state kinetics to establish the basic catalytic parameters. Implement a systematic variation of one substrate concentration while keeping the other fixed to determine Km and Vmax values. Then perform product inhibition studies and dead-end inhibitor analyses to distinguish between ordered, random, or ping-pong mechanisms. For ribH, which catalyzes a bisubstrate reaction, construct double-reciprocal (Lineweaver-Burk) plots with varying concentrations of one substrate at different fixed concentrations of the second substrate. The pattern of line intersection reveals the kinetic mechanism – intersecting lines indicate a sequential mechanism, while parallel lines suggest a ping-pong mechanism .

Pre-steady-state kinetics using stopped-flow techniques provides insights into transient catalytic intermediates. Monitor the reaction progress on the millisecond timescale by following either substrate disappearance or product formation spectroscopically. This approach can reveal rate-limiting steps and transient intermediates that are not detectable in steady-state analyses.

Site-directed mutagenesis is crucial for identifying catalytic residues. Based on sequence alignments with related enzymes and structural information, design mutations of candidate active site residues (particularly conserved acidic, basic, or polar residues). The following experimental matrix ensures comprehensive evaluation:

Combine these kinetic approaches with structural studies. X-ray crystallography of enzyme-substrate complexes, enzyme-product complexes, and enzyme-intermediate analogs provides static snapshots of the catalytic cycle. For capturing transient states, use substrate analogs that either react very slowly or form stable complexes without completing catalysis .

Implement isotope labeling and kinetic isotope effect (KIE) measurements to identify rate-determining steps and transition states. Primary KIEs (using isotopically labeled atoms directly involved in bond breaking/forming) and secondary KIEs (using isotopes at positions adjacent to the reaction center) provide mechanistic insights into the nature of transition states. For ribH, deuterium or carbon-13 labeling of specific positions in the substrates can reveal which bond-breaking steps are rate-limiting.

Finally, integrate experimental findings with computational methods. Quantum mechanical/molecular mechanical (QM/MM) simulations can model the energetics of proposed reaction pathways and identify transition states that may be difficult to capture experimentally. These computational predictions should then be tested with additional targeted experiments to validate the proposed mechanism.

What are the best approaches for determining substrate specificity of S. aureus ribH variants?

Characterizing the substrate specificity of Staphylococcus aureus 6,7-dimethyl-8-ribityllumazine synthase variants requires a systematic approach that combines biochemical assays, structural analysis, and computational methods. The following methodological framework provides comprehensive insights into substrate preference and catalytic efficiency:

Develop a substrate panel that includes both natural substrates and structural analogs. For ribH, this should include: (1) the natural substrate 3,4-dihydroxy-2-butanone 4-phosphate in both S and R enantiomeric forms; (2) structural analogs with modifications to the phosphate group (e.g., methylphosphonate, sulfate); (3) analogs with altered hydroxyl patterns; and (4) chain-length variants . For the second substrate, 5-amino-6-(D-ribitylamino)uracil, prepare analogs with modifications to the ribityl chain, the amino groups, or the uracil ring.

Implement a high-throughput initial screening followed by detailed kinetic characterization. The initial screen can utilize a spectrophotometric assay measuring product formation at 408-410 nm, while detailed kinetic characterization should determine the following parameters for each substrate:

For S. aureus ribH variants, it's particularly important to examine:

• Stereoselectivity: Compare activity with S versus R enantiomers of 3,4-dihydroxy-2-butanone 4-phosphate. Wild-type ribH shows preference for the S enantiomer but can use the R form with reduced efficiency . Mutations may alter this stereoselectivity pattern.

• Phosphate dependence: Test unphosphorylated 3,4-dihydroxy-2-butanone and variants with altered phosphate groups. Wild-type enzyme is unable to use unphosphorylated substrates , but variants may show altered preferences.

• pH and temperature profiles: Determine optimal conditions for each variant-substrate combination, as mutations can shift pH optima and thermal stability.

Combine biochemical data with structural analysis. If possible, obtain crystal structures of variant enzymes in complex with different substrates to visualize altered binding modes. In the absence of crystal structures, molecular docking and molecular dynamics simulations can predict binding pose changes and correlate with experimental findings.

For comprehensive substrate specificity profiling, consider implementing:

• Substrate competition assays: Measure enzyme activity with a mixture of substrates to determine preferential utilization under competitive conditions.

• Isothermal titration calorimetry (ITC): Directly measure thermodynamic parameters of substrate binding (ΔH, ΔS, ΔG) for different variants and substrates.

• Nuclear magnetic resonance (NMR): Monitor substrate-enzyme interactions in solution, particularly useful for detecting weak or transient interactions.

This integrated approach not only characterizes substrate specificity but also provides mechanistic insights into how specific residues contribute to substrate recognition and catalysis in S. aureus ribH.

What statistical approaches are most appropriate for analyzing ribH enzyme kinetics data?

Robust statistical analysis of enzyme kinetics data for recombinant S. aureus 6,7-dimethyl-8-ribityllumazine synthase requires careful consideration of data structure, appropriate model selection, and rigorous validation. The following methodological framework ensures statistically sound interpretation of ribH kinetic data:

Begin with exploratory data analysis (EDA) to visualize patterns and identify potential outliers. Create scatter plots of initial velocity versus substrate concentration, residual plots to check model adequacy, and Q-Q plots to assess normality. This visual exploration helps identify appropriate mathematical models for subsequent analysis . For ribH kinetics, non-linear relationships are expected following Michaelis-Menten or more complex models.

For model fitting, avoid the linearized Lineweaver-Burk approach despite its historical popularity, as it distorts error structure and overemphasizes data points at low substrate concentrations. Instead, implement direct nonlinear regression using weighted least squares, with weights inversely proportional to the variance at each point. Modern statistical software packages (R, GraphPad Prism, MATLAB) offer robust nonlinear fitting algorithms specifically designed for enzyme kinetics .

The following table outlines the appropriate statistical approaches for different kinetic scenarios:

For replicate measurements, implement mixed-effects models that properly account for both within-experiment variation and between-experiment variation. This approach is particularly valuable when combining data from multiple experimental runs or different enzyme preparations .

When comparing kinetic parameters (Km, Vmax, kcat) between wild-type and variant enzymes, avoid simple t-tests; instead, use analysis of covariance (ANCOVA) or bootstrap methods to generate confidence intervals, as kinetic parameters are derived values with complex error structures.

To determine statistical significance when comparing multiple enzyme variants or conditions, implement one-way ANOVA followed by appropriate post-hoc tests (Tukey's HSD for all pairwise comparisons or Dunnett's test when comparing treatments to a control). Before applying ANOVA, verify that the data meet the assumptions of normality and homogeneity of variance .

For more complex experimental designs with multiple factors (e.g., enzyme variant, pH, temperature, substrate type), use factorial ANOVA or linear mixed-effects models to properly capture interaction effects. These approaches can reveal how different factors collectively influence enzyme kinetics and identify synergistic or antagonistic effects .

How can I troubleshoot common issues in recombinant S. aureus ribH expression and purification?

Successfully producing and purifying recombinant Staphylococcus aureus 6,7-dimethyl-8-ribityllumazine synthase can be challenging due to issues with protein solubility, activity, and stability. The following systematic troubleshooting approach addresses common problems encountered during the expression and purification process:

Poor Expression Levels

When facing low protein expression, implement this diagnostic decision tree:

• Check codon optimization: S. aureus uses different codon preferences than E. coli. Analyze your construct for rare codons using tools like the Codon Usage Database. Consider synthetic gene optimization or co-expression with rare tRNA plasmids like pRARE .

• Evaluate promoter strength and induction: Test different IPTG concentrations (0.1-1.0 mM) and induction times. Collect samples at various time points post-induction (2, 4, 6, and overnight) to determine optimal induction parameters.

• Assess protein toxicity: If the protein is toxic to the host, switch to tightly controlled expression systems like pET with T7lysY or use lower growth temperatures (16-25°C) immediately after induction to reduce expression rate .

• Confirm construct integrity: Sequence verify your expression construct and perform Western blot analysis with antibodies against the affinity tag to confirm expression of full-length protein.

Protein Insolubility

If ribH forms inclusion bodies, try these sequential solutions:

• Lower the expression temperature to 16-20°C after induction while extending expression time to 16-20 hours.

• Modify buffer conditions by adding solubilizing agents in this order of increasingly aggressive intervention:

  • Add 5-10% glycerol to all buffers

  • Include 0.1-0.5% non-ionic detergents (Triton X-100 or NP-40)

  • Test different salt concentrations (150-500 mM NaCl)

  • Add low concentrations of urea (1-2 M) or arginine (50-100 mM)

• Create fusion constructs with solubility-enhancing partners such as MBP (maltose-binding protein), SUMO, or Thioredoxin, with appropriate protease cleavage sites for tag removal .

• If inclusion bodies persist, optimize refolding protocols using gradual dialysis from 8M urea or 6M guanidinium hydrochloride with a carefully controlled redox environment (5 mM GSH:0.5 mM GSSG ratio).

Purification Challenges

When facing purification issues, implement this methodological decision matrix:

Activity Loss

If purified ribH shows low enzymatic activity:

• Verify cofactor requirements: Test the addition of divalent cations (Mg²⁺, Mn²⁺) at 1-5 mM concentrations.

• Check for oxidation sensitivity: Add reducing agents (1-5 mM DTT or 2-10 mM β-mercaptoethanol) to all buffers.

• Assess aggregation state: Use size exclusion chromatography or dynamic light scattering to confirm proper oligomeric state. ribH typically forms specific oligomeric structures essential for activity.

• Confirm substrate quality: Verify the integrity and purity of substrates using analytical techniques (HPLC, MS), as 3,4-dihydroxy-2-butanone 4-phosphate is particularly sensitive to degradation.

Remember that recombinant S. aureus proteins expressed in E. coli can retain full biological activity when purified correctly, as demonstrated with other S. aureus enzymes . Systematic application of these troubleshooting approaches should resolve most expression and purification challenges.